Android app Apple app link

Moderna gains as FDA nod for next-gen COVID-19 vaccine

By Yahoo! Finance   |   2 weeks ago
Moderna gains as FDA nod for next-gen COVID-19 vaccine

Moderna's shares surged after FDA approved its new COVID-19 vaccine, mNEXSPIKE, for high-risk groups. The vaccine offers logistical flexibility and longer shelf life. Approval sets stage for company's combo flu/COVID vaccine.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.